Early-onset gastrointestinal cancer (EOGIC), defined as diagnosis before age...
This retrospective study, conducted at the University Hospitals of Leuven,...
Dr Hugo Couvert, resident in gastroenterology at the Jules Bordet Institute...
In the RATIONALE-306 trial, first-line treatment with tislelizumab (TIS) plus...
In the absence of direct head-to-head RCTs, a network meta-analysis was...
Dr Manon Verhé, fellow in gastroenterology at UZ Leuven discussed the results...
Prof Jean-Luc Van Laethem, principal investigator of the NALLONG study, shared...
Ms Zorana Maravic, CEO of Digestive Cancers Europe (DiCE), presented a...
Dr Willem Lybaert spoke at the ESMO GI 2025 congress with Prof Lorenza Rimassa...
Prof Eric van Cutsem and Prof Markus Möhler discussed recent findings from the...